Biomimetic hybrid Liposome–Exosome nanoparticle: Shining a light on Theranostic agents in Breast cancer — A Systematic Review
This systematic review evaluates exosome–liposome hybrid nanovesicles as a promising theranostic platform for breast cancer that enhances drug delivery and efficacy while identifying critical standardization and manufacturing challenges that must be addressed to enable clinical translation.